What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
His primary scientific interests are in Surgery, Hepatectomy, Internal medicine, Gastroenterology and Hepatocellular carcinoma.
His Surgery research integrates issues from Metastasis, Colorectal cancer, Radiofrequency ablation and Radiology.
His Hepatectomy study combines topics in areas such as Preoperative care, Mortality rate, Chi-squared distribution, Retrospective cohort study and Survival analysis.
His work in Internal medicine addresses issues such as Oncology, which are connected to fields such as Cetuximab and Angiogenesis.
His studies deal with areas such as Lesion and Surgical oncology as well as Gastroenterology.
Steven A. Curley has researched Hepatocellular carcinoma in several fields, including Hepatitis B, Incidence, Cirrhosis, Liver disease and Carcinoma.
His most cited work include:
- Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases (1379 citations)
- Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases (1030 citations)
- Radiofrequency Ablation of Unresectable Primary and Metastatic Hepatic Malignancies: Results in 123 Patients (1002 citations)
What are the main themes of his work throughout his whole career to date?
Steven A. Curley focuses on Surgery, Internal medicine, Gastroenterology, Hepatocellular carcinoma and Cancer.
His research in Surgery intersects with topics in Colorectal cancer, Radiofrequency ablation and Metastasis.
His Internal medicine study frequently draws parallels with other fields, such as Oncology.
His Gastroenterology study integrates concerns from other disciplines, such as Odds ratio, Surgical oncology, Incidence and Hepatitis.
Steven A. Curley combines subjects such as Liver transplantation, Transplantation, Cirrhosis, Hepatitis C and Carcinoma with his study of Hepatocellular carcinoma.
His Cancer research focuses on Cancer research and how it connects with Cytotoxicity and Pathology.
He most often published in these fields:
- Surgery (39.19%)
- Internal medicine (32.60%)
- Gastroenterology (17.95%)
What were the highlights of his more recent work (between 2011-2020)?
- Internal medicine (32.60%)
- Surgery (39.19%)
- Hepatectomy (16.85%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Surgery, Hepatectomy, Cancer and Oncology.
In his research on the topic of Internal medicine, Radiation therapy is strongly related with Gastroenterology.
His Surgery research incorporates themes from Incidence and Cohort.
His research integrates issues of Survival rate, Odds ratio, Neoadjuvant therapy and Retrospective cohort study in his study of Hepatectomy.
His studies in Cancer integrate themes in fields like Cancer research and Hyperthermia.
The Hepatocellular carcinoma study combines topics in areas such as Prospective cohort study and Carcinoma.
Between 2011 and 2020, his most popular works were:
- RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. (219 citations)
- Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach (178 citations)
- Kinetic Growth Rate after Portal Vein Embolization Predicts Posthepatectomy Outcomes: Toward Zero Liver-Related Mortality in Patients with Colorectal Liver Metastases and Small Future Liver Remnant (177 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
His primary areas of study are Hepatectomy, Surgery, Internal medicine, Survival rate and Hepatocellular carcinoma.
His work deals with themes such as Odds ratio, Metastasectomy and Breast cancer, which intersect with Hepatectomy.
His Surgery research is multidisciplinary, incorporating elements of Radiology and Incidence.
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Oncology.
Steven A. Curley has researched Survival rate in several fields, including Long term survival, Liver resections, Major hepatectomy, Proportional hazards model and Prospective cohort study.
His Hepatocellular carcinoma research is multidisciplinary, incorporating perspectives in Hepatic metastasis, Nuclear medicine, Carcinoma, Complication and Radiofrequency ablation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
